Atlas Trials

Pharmacokinetics and Bioequivalence of Two Empagliflozin, With Evaluation in Healthy Jordanian Subjects Under Fasting and Fed Conditions

Clinical trial NCT05229796 · COMPLETED

Trial details

NCT number
NCT05229796
Sponsor
Mutah University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Pharmacokinetic Parameters
Start date
2021-05-17
Primary completion
2021-12-10
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.